About
Molly Grammel is a partner in Goodwin’s Intellectual Property Litigation practice and is a member of the firm’s Life Sciences Disputes group. She has extensive federal trial experience in cutting-edge technology IP litigation that spans a diverse set of industries, including biologic and biosimilar drugs and artificial intelligence and machine learning.
Practice areas
Intellectual Property LitigationLife Sciences DisputesPatent Litigation
Office
Expertise
Life SciencesBiologicsBiosimilarsArtificial IntelligenceMachine Learning
Education
- JD, 2013 University of Pennsylvania Law School (magna cum laude, Levy Scholarship)
- BA, 2010 University of California, Los Angeles (magna cum laude, Phi Beta Kappa, college honors program)